Vorsitz: C. K. Naber (Essen), U. Schäfer (Hamburg)
| (V163) | Comparative 18 months follow-up of transcatheter aortic valve implantation to medical therapy in symptomatic aortic stenosis |
| R. Hoffmann, R. Herpertz, B. Almutairi, R. Stöhr, K. Brehmer, R. Autschbach, N. Marx, G. Dohmen (Aachen) | |
| (V164) | Outcome in patients with severe reduced left ventricular function undergoing TAVI. First results of the prospective multi-centre German Transcatheter Aortic Valve Interventions-Registry |
| U. Schäfer, K.-H. Kuck, R. Zahn, U. Gerckens, E. Grube, A. Linke, H. Sievert, H. Eggebrecht, R. Hambrecht, S. Sack, K. E. Hauptmann, G. Richardt, H.-R. Figulla, J. Senges on behalf of ACMS (Hamburg, Ludwigshafen, Siegburg, Essen, Leipzig, Frankfurt am Main, Bremen, München, Trier, Bad Segeberg, Jena) | |
| (V165) | Survival in high risk patients with severe aortic stenosis: Intervention versus surgery versus medical therapy |
| S. Bleiziffer, J. Socha, H. Ruge, M. Kornek, G. Brockmann, N. Piazza, A. Hutter, A. Opitz, R. Bauernschmitt, R. Lange (München) | |
| (V166) | Comparison of transcatheter aortic valve implantation versus surgical aortic valve replacement in a high-risk patient population: a propensity score analysis |
| L. Conradi, H. Treede, M. Silaschi, O. W. Franzen, M. Seiffert, S. Baldus, J. Schirmer, T. Meinertz, H. Reichenspurner (Hamburg) | |
| (V167) | Profitieren Patienten mit hochgradig eingeschränkter linksventrikulärer Pumpfunktion von einem interventionellen Aortenklappenersatz? |
| M. B. Arnold, S. Achenbach, J. Ludwig, R. Feyrer, S. Loders, W. G. Daniel, M. Weyand, S. Ensminger (Erlangen) | |
| (V168) | Prognostic Importance of Pulmonary Hypertension in Patients Undergoing Aortic Valve Replacement for Severe Aortic Stenosis |
| C. S. Zürn, C. Eick, K. Rizas, B. Woernle, C. Stoleriu, U. Stock, M. Gawaz, C. Herdeg, A. Bauer (Tübingen, Ostfildern) |